Equity Capital Markets

Company · CIK 1810031

Freeline Therapeutics Holdings plc

CIK1810031 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inX0
Business addressUnited Kingdom
Listedno ticker on SEC record today
First annual or quarterly report2021-03-31

Offerings

2 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-259444
ShelfEffective
 2021-09-102024-02-237
333-239938
IPOFinal prospectus
 2020-07-172020-08-104

Filings

13
FiledFilingRegistrationAccession
2024-02-23EFFECTDeclared effective 333-2594449999999995-24-000522
2022-04-07424B5Shelf takedown 333-2594440001193125-22-099022
2022-03-22424B5Shelf takedown 333-2594440001193125-22-081630
2022-03-11424B5Shelf takedown 333-2594440001193125-22-072687
2021-11-17424B5Shelf takedown 333-2594440001193125-21-332449
2021-09-22EFFECTDeclared effective 333-2594449999999995-21-003629
2021-09-10F-3Shelf registered 333-2594440001193125-21-269951
2020-08-10424B4Final prospectus 333-2399380001193125-20-215070
2020-08-06EFFECTDeclared effective 333-2401259999999995-20-002060
2020-08-06EFFECTDeclared effective 333-2399389999999995-20-002056
2020-08-03F-1/AAmendment 333-2399380001193125-20-207194
2020-07-17F-1Registration filed 333-2399380001193125-20-194813
2020-05-07DRSDraft made public 377-031580000950123-20-004065

All filings of this company · CSV